Meta is preparing to launch two new Ray-Ban smart glasses models designed specifically for prescription wearers, according to a Bloomberg report published on Thursday. The models, codenamed Scriber and Blazer, were first spotted in Federal Communications Commission filings and are expected to reach consumers as early as next week. They do not represent a new generation of hardware. They represent something potentially more important: a distribution strategy.

Prescription eyewear accounts for roughly 69 per cent of the $223 billion global eyewear market. Meta sold more than seven million Ray-Ban and Oakley AI frames in 2025, an impressive figure for a product category that barely existed three years ago, but a rounding error against the estimated 1.5 billion people worldwide who wear corrective lenses. The new models are Meta’s clearest attempt yet to move smart glasses from consumer electronics into mainstream optical retail, where the customers, the margins, and the scale are all substantially larger.

What the new models are, and what they are not

Scriber and Blazer are non-display AI glasses, similar in capability to the existing Ray-Ban Meta line: camera, microphone, speakers, and Meta AI integration, but no screen. Blazer will come in regular and large sizes; Scriber appears to be a single-size offering. Both include Wi-Fi 6 UNII-4 band support, an upgrade over current models, and will ship with charging cases.

The distinction matters because Meta already sells a display-equipped model. The Ray-Ban Meta Display, launched at Connect 2025, includes a full-colour heads-up display, a 12-megapixel camera with 3x zoom, and pairs with a neural wristband that reads muscle signals to navigate the interface. It costs $799. Orion, Meta’s full augmented reality prototype with holographic displays, remains a research project with no consumer launch date.

Scriber and Blazer sit below both in the product hierarchy. Their purpose is not to showcase Meta’s most advanced technology but to put Meta AI into the frames that people already need to buy. The insight behind the move is straightforward: if someone requires prescription lenses and is going to spend several hundred dollars at an optician regardless, the incremental cost of making those lenses smart drops significantly. Mark Zuckerberg made the strategic logic explicit on a recent earnings call, noting that “billions of people wear glasses or contacts for vision correction” and suggesting it is “hard to imagine a world in several years where most glasses that people wear aren’t AI glasses.”

The EssilorLuxottica question

The prescription pivot also runs directly into the most complex relationship in Meta’s hardware business. EssilorLuxottica, the Franco-Italian conglomerate that owns Ray-Ban, Oakley, LensCrafters, and Sunglass Hut, manufactures all of Meta’s smart glasses and controls the optical retail channel through which the new models will be sold. The partnership has delivered results, but it has also generated friction.

Bloomberg reported in February that the two companies are working through disagreements over pricing and strategy. EssilorLuxottica’s adjusted gross margin fell 2.6 percentage points in 2025 to 60.9 per cent, partly because of the higher component costs that smart glasses require compared with conventional frames. Meta wanted to offer Black Friday discounts in 2023; EssilorLuxottica, which guards its luxury positioning carefully, rejected the idea. The tension is structural: Meta wants to maximise adoption and lock users into its AI ecosystem. EssilorLuxottica wants to protect margins on a product line that is eroding them.

Prescription models could ease that tension. Prescription lenses carry higher retail prices and fatter margins than non-prescription sunglasses. The lens coatings, custom grinding, and fitting appointments that prescription orders require generate additional revenue at every stage of the value chain. If smart glasses move into the prescription channel at scale, the economics improve for EssilorLuxottica even as volumes increase for Meta. The companies are reportedly considering doubling their combined production target to 20 million units per year, up from an estimated 10 million capacity by the end of 2026.

The risks in the optician’s chair

Selling smart glasses through optical retail introduces complications that consumer electronics channels do not. Opticians are trained to fit lenses, not to explain AI assistants, camera privacy settings, or software updates. The customer experience in a LensCrafters is fundamentally different from the experience in a Meta Store or an Apple Store, and the staff training, product support, and return handling required for a connected device are orders of magnitude more complex than for a pair of Wayfarers.

There is also the legal exposure. Solos Technology filed a patent infringement suit against Meta and EssilorLuxottica in January 2026, claiming that the Ray-Ban Meta line violates several patents covering core smart eyewear technologies and seeking “multiple billions of dollars” in damages. A second patent front, on top of the partnership tension and the margin pressure, adds risk to a product line that Meta is treating as the foundation of its wearable AI strategy.

The smart glasses market itself is growing rapidly, from an estimated $2.5 billion in 2025 to a projected $14.4 billion by 2033 according to Grand View Research, but nearly all of that growth is speculative and dependent on whether consumers will choose connected frames when ordinary ones are cheaper, lighter, and carry no privacy concerns. Meta’s bet is that AI functionality, specifically the ability to ask questions, get real-time information, and interact with digital services without reaching for a phone, will be compelling enough to overcome those objections.

Scriber and Blazer are not the product that will test that bet definitively. They are the product that puts Meta’s AI into opticians’ fitting trays, onto the faces of people who were going to buy new glasses anyway, and into a distribution channel that reaches billions of potential customers. The technology is incremental. The strategic ambition is not.